Stockscreener 앱 받기
1.35
0.00%
0.00
시간 외 거래:
1.35
전일 마감가:
$1.35
열려 있는:
$1.35
하루 거래량:
75,740
Relative Volume:
1.93
시가총액:
$63.18M
수익:
$8.98M
순이익/손실:
$-48.79M
주가수익비율:
-1.6939
EPS:
-0.797
순현금흐름:
$-36.77M
1주 성능:
+0.00%
1개월 성능:
-25.41%
6개월 성능:
-42.31%
1년 성능:
-47.88%
1일 변동 폭
$1.30
$1.35
1주일 범위
$1.30
$1.4199
52주 변동 폭
$1.28
$2.9319
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.35 | 63.18M | 8.98M | -48.79M | -36.77M | -0.797 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-02 | 개시 | Maxim Group | Buy |
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD (NSPR) schedules 2026 shareholder meeting on director slate and share authorization - Stock Titan
InspireMD : April 2026 Investor Deck - marketscreener.com
Shareholder Lawsuit Launched Against InspireMD - National Today
After plunging 15.2% in 4 weeks, here's why the trend might reverse for InspireMD (NSPR) - MSN
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
InspireMD (NSPR) asks shareholders to approve 150M→250M share increase - Stock Titan
After Dropping 15.2% Over the Past Four Weeks, This Is Why InspireMD (NSPR) Could See a Turnaround - Bitget
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) - Yahoo Finance
InspireMD (NYSE:NSPR) Trading Down 6.7%What's Next? - MarketBeat
Published on: 2026-04-06 18:18:37 - baoquankhu1.vn
InspireMD, Inc. Enters Equity Distribution Agreement with BTIG, LLC – SEC 8-K Filing Details (April 2026) - Minichart
InspireMD Establishes New $75 Million ATM Program - TipRanks
According to the latest submitted documents, medical device company InspireMD Inc. has signed an equity distribution agreement with the sales agent. - Bitget
InspireMD Launches $75 Million At-The-Market Equity Program With BTIG - TradingView — Track All Markets
InspireMD (NSPR) sets $75M BTIG equity distribution agreement - Stock Titan
InspireMD (NSPR) launches up to $75M ATM program with BTIG as agent - Stock Titan
NSPR Technical Analysis & Stock Price Forecast - Intellectia AI
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - The Manila Times
InspireMD to Present at 25th Annual Needham Virtual Healthcare Conference - National Today
Stroke-device maker InspireMD will speak at Needham's April 14 webcast - Stock Titan
Stock Market Recap: Is InspireMD Inc stock risky to hold nowMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - MSN
Published on: 2026-03-28 05:12:59 - baoquankhu1.vn
Market Trends: Will InspireMD Inc stock hit new highs in YEAR2026 Technical Overview & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
CEO Moves: Will InspireMD Inc stock hit new highs in YEAR2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
InspireMD tops Q4 estimates as revenue jumps, shares rise in premarket trading - MSN
Geopolitics Watch: Can InspireMD Inc keep up with sector leadersMarket Risk Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
InspireMD Q2 2025 Earnings Preview - MSN
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains US traction - MSN
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR) - The Globe and Mail
InspireMD, Inc. (NSPR) reports Q4 loss, beats revenue estimates - MSN
InspireMD revenue up 62% to USD 3.1M in Q4 2025 - Medical Buyer
Returns Recap: Can InspireMD Inc outperform in the next rallyDay Trade & Safe Entry Trade Reports - baoquankhu1.vn
InspireMD Reports 62% Q4 Revenue Growth and Sets 2026 Outlook for CGuard Prime Carotid Stent System - Minichart
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption - TipRanks
Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats By Investing.com - za.investing.com
InspireMD earnings beat by $0.05, revenue topped estimates - Investing.com Canada
InspireMD, Inc. (NSPR) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats - Investing.com
InspireMD, Inc. Overview: CGuard Carotid Stent Technology, Business Strategy, and Market Leadership in Stroke Prevention 72 - Minichart
InspireMD Reports Strong Q4 2025 Growth and Expansion - TipRanks
FDA PMA and global expansion reshape InspireMD (NSPR) carotid focus - Stock Titan
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
InspireMD, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
InspireMD Q4 net income USD -11.761 million - marketscreener.com
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
INSPIREMD ($NSPR) Releases Q4 2025 Earnings - Quiver Quantitative
InspireMD (NSPR) revenue climbs 28% in 2025 as net loss widens - Stock Titan
InspireMD Q4 revenue rises 62%, beats estimates - TradingView
NSPR: Q4 2025 revenue surged 62% year-over-year, with 2026 revenue growth projected at up to 65% - TradingView
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):